Market Cap 27.47B
Revenue (ttm) 10.38B
Net Income (ttm) 1.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 19.21
Profit Margin 0.01%
Debt to Equity Ratio 0.59
Volume 14,338
Avg Vol 22,776
Day's Range N/A - N/A
Shares Out 440.00M
Stochastic %K 97%
Beta 0.54
Analysts Sell
Price Target $51.50

Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 41 61 324 11 11
Address:
Centralbahnstrasse 4, Basel, Switzerland
Latest News on SDZNY
No data available.